BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30448564)

  • 21. Cellular prion protein is implicated in the regulation of local Ca2+ movements in cerebellar granule neurons.
    Lazzari C; Peggion C; Stella R; Massimino ML; Lim D; Bertoli A; Sorgato MC
    J Neurochem; 2011 Mar; 116(5):881-90. PubMed ID: 21214552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation.
    Perrier V; Solassol J; Crozet C; Frobert Y; Mourton-Gilles C; Grassi J; Lehmann S
    J Neurochem; 2004 Apr; 89(2):454-63. PubMed ID: 15056288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of STI1-mediated neuronal survival and differentiation in disease-associated mutations of prion protein.
    Landemberger MC; de Oliveira GP; Machado CF; Gollob KJ; Martins VR
    J Neurochem; 2018 Jun; 145(5):409-416. PubMed ID: 29337365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circumventing tolerance to the prion protein (PrP): vaccination with PrP-displaying retrovirus particles induces humoral immune responses against the native form of cellular PrP.
    Nikles D; Bach P; Boller K; Merten CA; Montrasio F; Heppner FL; Aguzzi A; Cichutek K; Kalinke U; Buchholz CJ
    J Virol; 2005 Apr; 79(7):4033-42. PubMed ID: 15767405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP
    Hiller H; Yang C; Beachy DE; Kusmartseva I; Candelario-Jalil E; Posgai AL; Nick HS; Schatz D; Atkinson MA; Wasserfall CH
    Diabetologia; 2021 Oct; 64(10):2279-2291. PubMed ID: 34274990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections.
    Watts JC; Drisaldi B; Ng V; Yang J; Strome B; Horne P; Sy MS; Yoong L; Young R; Mastrangelo P; Bergeron C; Fraser PE; Carlson GA; Mount HT; Schmitt-Ulms G; Westaway D
    EMBO J; 2007 Sep; 26(17):4038-50. PubMed ID: 17703189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcellular distribution of the prion protein in sickness and in health.
    Godsave SF; Peters PJ; Wille H
    Virus Res; 2015 Sep; 207():136-45. PubMed ID: 25683509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolongation of prion disease-associated symptomatic phase relates to CD3+ T cell recruitment into the CNS in murine scrapie-infected mice.
    Sacquin A; Chaigneau T; Defaweux V; Adam M; Schneider B; Bruley Rosset M; Eloit M
    Brain Behav Immun; 2012 Aug; 26(6):919-30. PubMed ID: 22522067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cellular prion protein (PrP(C)): its physiological function and role in disease.
    Westergard L; Christensen HM; Harris DA
    Biochim Biophys Acta; 2007 Jun; 1772(6):629-44. PubMed ID: 17451912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-Cleavage of cellular prion protein.
    Liang J; Kong Q
    Prion; 2012; 6(5):453-60. PubMed ID: 23052041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and functions of cellular prion proteins in immunocytes.
    Zhang B; Shen P; Yin X; Dai Y; Ding M; Cui L
    Scand J Immunol; 2020 Mar; 91(3):e12854. PubMed ID: 31785109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shedding light on prion disease.
    Glatzel M; Linsenmeier L; Dohler F; Krasemann S; Puig B; Altmeppen HC
    Prion; 2015; 9(4):244-56. PubMed ID: 26186508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular prion proteins in humans and cattle but not sheep are characterized by a low-solubility phenotype.
    Kuczius T; Groschup MH
    Comp Immunol Microbiol Infect Dis; 2013 Dec; 36(6):599-605. PubMed ID: 23948376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cellular and pathologic prion protein.
    Gill AC; Castle AR
    Handb Clin Neurol; 2018; 153():21-44. PubMed ID: 29887138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
    Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
    Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
    Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
    Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
    Prion; 2014; 8(4):314-8. PubMed ID: 25482603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion protein protects mice from lethal infection with influenza A viruses.
    Chida J; Hara H; Yano M; Uchiyama K; Das NR; Takahashi E; Miyata H; Tomioka Y; Ito T; Kido H; Sakaguchi S
    PLoS Pathog; 2018 May; 14(5):e1007049. PubMed ID: 29723291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.